Individuals with asymptomatic left ventricular systolic dysfunction in the community are at high risk for CHF and death, highlighting the need for optimal therapy even in mild cases.
Individuals with ALVD in the community are at high risk of CHF and death, even when only mild impairment of EF is present. Additional studies are needed to define optimal therapy for mild ALVD.
Wang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: